Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Podcast | Sexual health in older age

Dr Holly Thomas helps us unpack the needlessly taboo subject of sex and sexual health in women of older age.

Listen now
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in:

01-10-2019 | Bevacizumab | Case report

Bevacizumab

Cluster endophthalmitis caused by Stenotrophomonas maltophilia with toxic anterior segment syndrome due to off-label treatment: 3 case reports

Published in: Reactions Weekly | Issue 1/2019

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
…
Literature
Metadata
Title
Bevacizumab
Cluster endophthalmitis caused by Stenotrophomonas maltophilia with toxic anterior segment syndrome due to off-label treatment: 3 case reports
Publication date
01-10-2019
Publisher
Springer International Publishing
Keyword
Bevacizumab
Published in
Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-69800-z

Other articles of this Issue 1/2019

Ambrisentan

Arsenic trioxide/tretinoin

Quetiapine/rivastigmine

Belantamab-mafodotin

Busulfan

Vedolizumab